Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Qualitative bone defect in uremic osteosclerosis

R S Weinstein, L J Sappington

    Metabolism: Clinical and Experimental
    |August 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Issues in modern bone histomorphometry.

    Bone·2011
    Same author

    Spectroscopic markers of bone quality in alendronate-treated postmenopausal women.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2008
    Same author

    Telemedicine and telepresence for trauma and emergency care management.

    Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society·2008
    Same author

    Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density.

    Endocrinology·2006
    Same author

    Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE study.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2004
    Same author

    Reversal of bone loss in mice by nongenotropic signaling of sex steroids.

    Science (New York, N.Y.)·2002
    Same journal

    Ablation of microglial estrogen receptor alpha predisposes male mice to diet-induced obesity.

    Metabolism: clinical and experimental·2026
    Same journal

    Pathophysiology-based subtypes of individuals at high-risk of type 2 diabetes: multi-omics profiles and lifestyle differences across subtypes.

    Metabolism: clinical and experimental·2026
    Same journal

    A thermosensitive TET-Parkin epigenetic axis couples mitochondrial quality control to adaptive thermogenesis in adipose tissue.

    Metabolism: clinical and experimental·2026
    Same journal

    Raffinose targets the NQO1/NF-κB axis to attenuate DON-driven microglial activation and neuroinflammation via metabolic reprogramming.

    Metabolism: clinical and experimental·2026
    Same journal

    Endothelial NPR-C promotes insulin resistance via Caveolin-1-mediated insulin transcytosis.

    Metabolism: clinical and experimental·2026
    Same journal

    Macrophage-enriched GPR91 aggravates acute liver injury by inhibiting efferocytosis via the AC/cAMP/PPARγ pathway.

    Metabolism: clinical and experimental·2026
    See all related articles

    Uremic osteodystrophy can cause increased bone volume (osteosclerosis) that paradoxically has lower bone density. This qualitative bone defect in chronic kidney disease patients is linked to poor mineralization, despite higher bone formation markers.

    Area of Science:

    • Nephrology
    • Orthopedics
    • Bone Metabolism

    Background:

    • Osteosclerosis, increased trabecular bone volume, is a common feature of uremic osteodystrophy.
    • Radiographic density in osteosclerosis can be misleading, as pain and fractures may still occur.
    • Reduced bone quality, not just quantity, contributes to skeletal complications in chronic kidney disease.

    Purpose of the Study:

    • To investigate the relationship between bone quantity and quality in uremic and non-uremic osteopenic patients.
    • To determine if increased radiographic bone density in uremia correlates with actual bone mineralization.
    • To explore the role of serum phosphorus and parathyroid hormone in uremic bone disease.

    Main Methods:

    • Histomorphometric analysis and photon absorption measurements of transileal bone biopsies.

    Related Experiment Videos

  • Comparison of bone core density, trabecular bone volume, and mineralized bone volume in uremic and non-uremic osteopenic groups.
  • Correlation analysis with serum phosphorus and parathyroid hormone (iPTH) levels.

    • Main Results:

    • In uremic patients, bone core density was not significantly related to bone volume but negatively correlated with osteoid volume.
    • Non-uremic osteopenic patients showed a direct relationship between bone density and bone volume.
    • Elevated serum phosphorus and iPTH levels were associated with osteosclerosis and negatively correlated with bone core density in uremic patients.

    Conclusions:

    • Uremic bone disease exhibits a qualitative defect where increased bone volume (osteosclerosis) is associated with reduced mineralization.
    • Elevated iPTH and phosphorus levels in uremia may stimulate bone formation with a poorly mineralized, woven bone architecture.
    • Radiographic osteosclerosis in uremia does not necessarily indicate increased normal bone mass; it can mask underlying bone fragility.